MedPath

A randomized controlled clinical Trial for Qingre Huayu Formula on left ventricular remodeling in patients with ST segment elevation myocardial infarctio

Phase 2
Not yet recruiting
Conditions
ST segment elevation myocardial infarction
Registration Number
ITMCTR2000003834
Lead Sponsor
Shuguang Hospital of Shanghai University of Traditional Chinese
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

(1) patient aged 18 and 85 years old;
(2) It conforms to the diagnosis of acute myocardial infarction in Western medicine, and is diagnosed as death heartache by Traditional Chinese medicine. The syndrome belongs to the syndrome of blood stasis and obstruction;
(3) Patients with single-vessel, double-vessel or three-vessel coronary lesions diagnosed by emergency coronary angiography and and PCI with onset time less than 6 hours.

Exclusion Criteria

1. Patients who did not undergo coronary angiography +PCI;
2. Pregnant women and lactating women;
3. Chest pain caused by other heart diseases, severe cardiac neurosis, menopausal syndromes, hyperthyroidism, cervical spondylosis, biliary disease, stomach and esophageal reflux, etc.;
4. Patients with severe heart and lung dysfunction and severe arrhythmia;
5. Patients with multiple organs such as heart, liver, brain and kidney, as well as hematopoietic system and other serious primary diseases, malignant tumors, or mental diseases;
6. Patients who are known to be allergic to such drugs and have a severe allergic constitution;
7. Recent (within 1 month) major trauma or surgical history, etc.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.